Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer
Chinese Journal of Cancer · 05.10.2012 · 31 (10) · 463-470
DOI: 10.5732/cjc.012.10216 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chinese Journal of Cancer, erschienen am 05.10.2012. Verfasst von Yan-Fang Guan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Clinical Molecular Diagnostic Engineering Laboratory, BGI-Shenzhen, Shenzhen, Guangdong, People's Republic of China. Hauptthemen laut MEDLINE: Mutation, Precision Medicine. Die Arbeit wurde bisher 105-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Shenzhen Clinical Molecular Diagnostic Engineering Laboratory, BGI-Shenzhen, Shenzhen, Guangdong, People's Republic of China.
Zitieren
APA
Guan, Y. F., Li, G. R., Wang, R. J., Yi, Y. T., Yang, L., Jiang, D., Zhang, X. P., & Peng, Y. (2012). Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer. Chinese Journal of Cancer, 31(10), 463-470. https://doi.org/10.5732/cjc.012.10216
Vancouver
Guan YF, Li GR, Wang RJ, Yi YT, Yang L, Jiang D, et al. Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer. Chinese Journal of Cancer. 2012;31(10):463-470. doi:10.5732/cjc.012.10216
BibTeX
@article{Guan2012,
author = {Guan, Yan-Fang and Li, Gai-Rui and Wang, Rong-Jiao and Yi, Yu-Ting and Yang, Ling and Jiang, Dan and Zhang, Xiao-Ping and Peng, Yin},
title = {Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer},
journal = {Chinese Journal of Cancer},
year = {2012},
volume = {31},
number = {10},
pages = {463--470},
doi = {10.5732/cjc.012.10216}
}
EUVIMED